<html>
<head>PUBMED IDs for SMCC</head>
<body bgcolor='#C5F0F2'><h1>SMCC</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9332369/'>Expression, genomic structure and high resolution mapping to 19p13.2 of the human smooth muscle cell calponin gene.</a> October 23  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/10198638/'>Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators.</a> April 13  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10235266/'>Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex.</a> May 11  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10332074/'>Cellular delivery of hammerhead ribozymes conjugated to a transferrin receptor antibody.</a> May 20  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/11857910/'>[The etiology of steroid hormone insensitivity: nuclear cofactors and subnuclear architecture].</a> February 23  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12101254/'>TRAP/SMCC/mediator-dependent transcriptional activation from DNA and chromatin templates by orphan nuclear receptor hepatocyte nuclear factor 4.</a> July 9  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/15681094/'>Monoclonal antibody-polyethyleneimine conjugates targeting Her-2/neu or CD90 allow cell type-specific nonviral gene delivery.</a> February 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/19010901/'>Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate.</a> November 18  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19350537/'>An investigation of the relationship between SULT1A1 Arg(213)His polymorphism and lung cancer susceptibility in a Turkish population.</a> August 21  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/22475266/'>Drug interaction potential of trastuzumab emtansine (T-DM1) combined with pertuzumab in patients with HER2-positive metastatic breast cancer.</a> June 14  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/25062087/'>A lysosome-targeted drug delivery system based on sorbitol backbone towards efficient cancer therapy.</a> May 20  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25654285/'>[Effect of miR-30a-5p on the proliferation, apoptosis, invasion and migration of SMCC-7721 human hepatocellular carcinoma cells].</a> September 9  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26502640/'>Delivery of PUMA Apoptosis Gene Using Polyethyleneimine-SMCC-TAT/DNA Nanoparticles: Biophysical Characterization and In Vitro Transfection Into Malignant Melanoma Cells.</a> December 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26633129/'>Antibody-coupled siRNA as an efficient method for in vivo mRNA knockdown.</a> April 5  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26814075/'>[Effect of IFN-Î± on hepatic cancer SMCC-7721 cell via PI3K/Akt signaling pathway and related mechanism research].</a> April 27  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27510817/'>Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo.</a> August 12  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27805249/'>Tumor-suppressive role of HACE1 in hepatocellular carcinoma and its clinical significance.</a> November 3  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28460618/'>Specific targeting of HER2-positive head and neck squamous cell carcinoma line HN5 by Idarubicin-ZHER2 affibody conjugate.</a> May 4  2017<br></body></html>
